微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 8.8% | 168.29% | 49.15% | 34/160 | 4.14% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 5.9% | 218.92% | 93.44% | 29/160 | 2.6% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 3.05% | 154.17% | 7.77% | 31/160 | 2.3% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 2.83% | -29.07% | -13.72% | 83/160 | -0.96% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 3.28% | -2.67% | 77.3% | 88/160 | 2.37% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 1.85% | -17.41% | 54.17% | 87/160 | 1.51% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 1.2% | 36.36% | -69.92% | 84/160 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 3.99% | 19.46% | 18.4% | 84/160 | 0.8% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 3.37% | -19.57% | 50.45% | 80/160 | 2.89% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 2.24% | -9.68% | 154.55% | 83/160 | 2.24% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 0.88% | -50% | -73.65% | 98/160 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 3.34% | -5.65% | -20.29% | 88/160 | 0.94% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 4.19% | 39.2% | 68.95% | 85/160 | 4.53% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 2.48% | 31.91% | 40.91% | 90/160 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 1.76% | 114.63% | -50.28% | 74/160 | 2.52% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 3.54% | -16.71% | 17.61% | 95/160 | 3.74% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 3.01% | -14.25% | 60.11% | 85/160 | 3.22% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 1.88% | -18.26% | 129.27% | 90/160 | 4.24% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | 0.82% | -33.87% | -80.71% | 73/160 | 2.24% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 4.25% | 33.23% | 21.08% | 94/160 | 2.78% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 3.51% | 10.73% | 52.61% | 81/160 | 7.61% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 2.3% | 1.77% | 85.48% | 81/160 | 5.05% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 1.24% | 0% | -61.13% | 80/160 | 2.46% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 3.19% | 23.17% | 0.63% | 104/160 | 7.09% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 3.17% | 24.8% | 40.27% | 84/160 | 7.26% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 2.26% | 109.26% | 82.26% | 80/160 | 4.65% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 1.24% | 103.28% | -52.12% | 74/160 | 2.55% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 2.59% | 236.36% | 1.97% | 105/160 | 9.66% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 2.54% | 93.89% | 135.19% | 82/160 | 8.31% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 1.08% | 20% | 77.05% | 95/160 | 5.59% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 0.61% | 1.67% | -20.78% | 74/160 | 2.1% | 河化股份 | 54.24% | 行业排名> |
| 2016-12-31 | 0.77% | 103.43% | -41.22% | 102/160 | 6.33% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 1.31% | 107.06% | 45.56% | 71/160 | 5.61% | 南新制药 | 81.7% | 行业排名> |
| 2016-06-30 | 0.9% | 107.63% | 50% | 78/160 | 3.53% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | 0.6% | 107.43% | 102.67% | 68/160 | 2.65% | 贝达药业 | 16.78% | 行业排名> |
| 2015-12-31 | -22.46% | -536.26% | -21.08% | 103/160 | 11.35% | 河化股份 | 19.29% | 行业排名> |
| 2015-09-30 | -18.55% | -487.27% | -57.2% | 77/160 | 7.22% | 一品红 | 58.17% | 行业排名> |
| 2015-06-30 | -11.8% | -472.24% | -46.22% | 82/160 | 4.9% | 华东医药 | 36.97% | 行业排名> |
| 2015-03-31 | -8.07% | -540.98% | -128.61% | 76/160 | 2.41% | 华东医药 | 26.63% | 行业排名> |